The MBL serum levels did not differ between the groups, in contrast to the CSF levels that significantly decreased in the AD group (154 ± 35 pg/mL) compared to the control group (276 ± 50 pg/mL). This evidence concerns the gene MBL2 and Alzheimer disease.